Amgen Cuts to Four in Media Review

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

LOS ANGELES Amgen has narrowed its estimated $40 million media review to Interpublic Group’s Initiative Media, Los Angeles; WPP Group’s MindShare and Mediaedge:cia; both New York; and Publicis Groupe’s Starcom, Chicago, sources said.

Final presentations are scheduled for the first week in April with a decision expected by the middle of the month. The assignment is for direct-to-consumer advertising for Neulasta, the Thousand Oaks, Calif.-based biotech firm’s chemotherapy infection fighting drug, according to sources. Select Resources International, West Hollywood, Calif.,

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in